In “Artificial Intelligence in Health Care: The Hope, the Hype, the Promise, the Peril,” NAM members representing Baltimore-based Johns Hopkins University, Boston-based Harvard Medical School, OptumLabs and Epic, among many others, highlighted the need for greater caution and consensus-building before deploying AI to prevent “user disillusionment, another AI winter or further exacerbation of existing health- and technology-driven disparities.”
“AI has the potential to revolutionize healthcare. However, as we move into a future supported by technology together, we must ensure high data quality standards, that equity and inclusivity are always prioritized, that transparency is use-case-specific, that new technologies are supported by appropriate and adequate education and training, and that all technologies are appropriately regulated and supported by specific and tailored legislation,” NAM wrote in a Dec. 17 news release.
View the full report here.
More articles on AI:
Mayo Clinic partner Eko earns FDA ‘breakthrough device’ designation
St. Jude study: AI blood test improves infection predictions for leukemia patients
Memorial Sloan Kettering spinoff raises $45M for AI pathology platform
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
